Thu, April 21, 2011
[ Thu, Apr 21st 2011 ] - Market Wire
Exelixis Announces May 3rd Webcast of Its First Quarter 2011 Financial Results Conference Call
[ Thu, Apr 21st 2011 ] - Market Wire
Amedisys Welcomes Robert Yungk as Chief Strategy Officer
[ Thu, Apr 21st 2011 ] - Market Wire
Caprius, Inc. Announces Approval and Closing of Merger
[ Thu, Apr 21st 2011 ] - Market Wire
Thermo Fisher Scientific to Present at the 36th A .. utsche Bank Health Care Conference on May 4, 2011
[ Thu, Apr 21st 2011 ] - Market Wire
Five Star Quality Care, Inc. First Quarter Conference Call Scheduled for Thursday, April 28th
[ Thu, Apr 21st 2011 ] - Market Wire
Merck and Sanofi Pasteur Initiate Phase III Study .. atric Combination Vaccine to Help Prevent Six Inf
[ Thu, Apr 21st 2011 ] - Market Wire
POZEN Announces May 5, 2011 Webcast of First Quarter 2011 Results
[ Thu, Apr 21st 2011 ] - Market Wire
Repligen Reports Preliminary Fiscal Year 2011 Fin .. Guidance and Development Goals for Fiscal Year 20
[ Thu, Apr 21st 2011 ] - Market Wire
Alexion Reports First Quarter 2011 Results
[ Thu, Apr 21st 2011 ] - Market Wire
Biogen Idec Reports First Quarter 2011 Results
[ Thu, Apr 21st 2011 ] - Market Wire
Covidien annuncia i risultati del secondo trimestre
[ Thu, Apr 21st 2011 ] - Market Wire
ICON Reports First Quarter 2011 Revenue up 5% to $229 Million and EPS of 21c
Wed, April 20, 2011
[ Wed, Apr 20th 2011 ] - Market Wire
Gilead Sciences Announces First Quarter 2011 Financial Results
[ Wed, Apr 20th 2011 ] - Market Wire
Electromed, Inc. Makes Minneapolis/St. Paul Business Journala?s Top 100 Public Companies List
[ Wed, Apr 20th 2011 ] - Market Wire
Health Management Associates, Inc. Executes Defin .. th the 132-Bed Tri-Lakes Medical Center, Batesvil
[ Wed, Apr 20th 2011 ] - Market Wire
Biomagnetics and Los Alamos National Laboratory A .. say for Tuberculosis Biomarker - Company Prepares
[ Wed, Apr 20th 2011 ] - Market Wire
Gilead and MicroDose Therapeutx Announce License .. o Develop MDT-637 for Treatment of Respiratory Sy
[ Wed, Apr 20th 2011 ] - Market Wire
Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter
[ Wed, Apr 20th 2011 ] - Market Wire
RTI Biologics Schedules 2011 First Quarter Earnings and Conference Call for April 28, 2011
[ Wed, Apr 20th 2011 ] - Market Wire
Rochea?s RTCA HT Instrument Adapts Real-Time Cell Analysis to a High-Throughput Format
[ Wed, Apr 20th 2011 ] - Market Wire
Acorda Therapeutics Announces Changes to Board of Directors
[ Wed, Apr 20th 2011 ] - Market Wire
The Ludwig Institute and Pro-Pharmaceuticals Disc .. he Ability of Anti-Tumor T Lymphocytes to Kill Tu
[ Wed, Apr 20th 2011 ] - Market Wire
Salix Pharmaceuticals Secures Additional Intellectual Property Relating to Rifaximin
[ Wed, Apr 20th 2011 ] - Market Wire
AngioDynamics to Present at Upcoming Investor Conferences in May 2011
Tue, April 19, 2011
[ Tue, Apr 19th 2011 ] - Market Wire
Adamis Completes Acquisition of a Technology for a Potential Universal Cancer Vaccine
[ Tue, Apr 19th 2011 ] - Market Wire
Furiex Acquires Full Exclusive License Rights to .. evelop and Commercialize JNJ-Q2 (fluoroquinolone)
[ Tue, Apr 19th 2011 ] - Market Wire
Medtronic Introduces the MARROWMAXa" Bone Marrow Aspiration Needle Kit
[ Tue, Apr 19th 2011 ] - Market Wire
International Stem Cell Corporation Updates on Ma .. ing Strategy of its Subsidiary Lifeline Skin Care
[ Tue, Apr 19th 2011 ] - Market Wire
Baxter International Shareholders Meeting
[ Tue, Apr 19th 2011 ] - Market Wire
LabCorp Commences Cash Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
[ Tue, Apr 19th 2011 ] - Market Wire
Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2011 Earnings Per Share of $1.12
[ Tue, Apr 19th 2011 ] - Market Wire
Precision NanoSystems and Alnylam Form New Delivery Collaboration
[ Tue, Apr 19th 2011 ] - Market Wire
Cytokinetics Announces Opening of Phase IIb Clini .. ulation of Omecamtiv Mecarbil in Patients With Ac
[ Tue, Apr 19th 2011 ] - Market Wire
Biogen Idec obtiene opinin positiva del CHMP y autorizacin de Health Canada para AVONEX PEN
[ Tue, Apr 19th 2011 ] - Market Wire
MedPro Safety Products and Greiner Bio-One GmbH A .. UETTE® Premium Safety Needle System Tube-Touch®
[ Tue, Apr 19th 2011 ] - Market Wire
Genmab and Seattle Genetics Expand Antibody-Drug Conjugate Collaboration
Mon, April 18, 2011
[ Mon, Apr 18th 2011 ] - Market Wire
Young Biotech Firms Seek Long Term Relevance
[ Mon, Apr 18th 2011 ] - Market Wire
CHMP beveelt uitbreiding TYSABRI-bijsluiter aan m .. or anti-JC virus als derde factor om risico PML v
[ Mon, Apr 18th 2011 ] - Market Wire
CHMP recomienda actualizar la etiqueta de TYSABRI .. ti-JCV como tercer factor para estratificar los r
[ Mon, Apr 18th 2011 ] - Market Wire
00 a.m. ET
[ Mon, Apr 18th 2011 ] - Market Wire
Community Health Systems to Release 1Q Earnings o .. April 28 to Discuss Financial Results and Address
[ Mon, Apr 18th 2011 ] - Market Wire
Prism Medical Announces Acquisition of Movement 2 Ltd.
[ Mon, Apr 18th 2011 ] - Market Wire
PROTOX ANNOUNCES MOVE TO SAN DIEGO AND SENIOR MANAGEMENT TRANSITION
[ Mon, Apr 18th 2011 ] - Market Wire
BioClinica to Release First Quarter 2011 Financial Results on May 4, 2011
[ Mon, Apr 18th 2011 ] - Market Wire
Le Comit© des m©dicaments usage humain (CHMP) r .. ©tiquetage de TYSABRI afin d'inclure le statut d
[ Mon, Apr 18th 2011 ] - Market Wire
CHMP empfiehlt Aktualisierung der Produktinformat .. me des JC-Virus-Antikrperstatus als dritten Fakto
[ Mon, Apr 18th 2011 ] - Market Wire
CML HealthCare Inc. Declares April Dividend
[ Mon, Apr 18th 2011 ] - Market Wire
CHMP raccomanda l'aggiornamento dell'etichetta de .. s di anticorpo anti virus JC come terzo fattore p
Sun, April 17, 2011
[ Sun, Apr 17th 2011 ] - Market Wire
Helix BioPharma Corp. to Participate in Upcoming .. n New York Focused on Women's Health and Wellness
[ Sun, Apr 17th 2011 ] - Market Wire
CHMP Recommends Updating TYSABRI Labeling with an .. as a Third Factor to Further Stratify Risk of PML
[ Sun, Apr 17th 2011 ] - Market Wire
D. Medical Enters US$10 Million Standby Equity Agreement
Fri, April 15, 2011
[ Fri, Apr 15th 2011 ] - Market Wire
ARCA biopharma Licenses Exclusive Worldwide Rights to Bucindolol Genetic Markers
[ Fri, Apr 15th 2011 ] - Market Wire
Aethlon Medical Discloses Interview on Therapeutic Strategies to Address Hepatitis C (HCV) and HIV
[ Fri, Apr 15th 2011 ] - Market Wire
Health Management Associates, Inc. Announces Firs .. Quarter 2011 Earnings Conference Call and Webcast
[ Fri, Apr 15th 2011 ] - Market Wire
Amedisys to Present at the 15th Annual Burkenroad Reports Investment Conference
[ Fri, Apr 15th 2011 ] - Market Wire
Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.
[ Fri, Apr 15th 2011 ] - Market Wire
Vertex Announces the Date of its First Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Apr 15th 2011 ] - Market Wire
Preliminary Injunction Ordered in POZEN Treximet Patent Litigation
[ Fri, Apr 15th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? Cancer Vaccine: Saf .. Results for Glioblastoma Trial Presented at Ameri
[ Fri, Apr 15th 2011 ] - Market Wire
Bydureona" Recommended for Approval in Europe
[ Fri, Apr 15th 2011 ] - Market Wire
Merck Reaffirms 2011 Non-GAAP EPS Target
[ Fri, Apr 15th 2011 ] - Market Wire
Repligen Announces Conference Call to Discuss Pre .. ancial Results and Fiscal Year 2012 Corporate Goa
[ Fri, Apr 15th 2011 ] - Market Wire
Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE® and SIMPONI®
Thu, April 14, 2011
[ Thu, Apr 14th 2011 ] - Market Wire
DaVita Hosts Nationwide Celebrations for 35,000 Teammates
[ Thu, Apr 14th 2011 ] - Market Wire
Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2011 Financial Results
[ Thu, Apr 14th 2011 ] - Market Wire
Synovis Life Technologies Receives 2011 Manufactu .. ear Award from Manufacturers Alliance Association
[ Thu, Apr 14th 2011 ] - Market Wire
Alliance HealthCare Services Announces Profession .. Radiology Services Acquisition of 24/7 Radiology
[ Thu, Apr 14th 2011 ] - Market Wire
Tornier Announces Launch of BioFiber® Surgical M .. Tendon Repair at Arthroscopic Surgery Conference
[ Thu, Apr 14th 2011 ] - Market Wire
Geron to Webcast Analyst and Investor Meeting on .. ompanya?s Cell Therapy Programs on April 19, 2011
[ Thu, Apr 14th 2011 ] - Market Wire
InSite Vision Updates Special Protocol Assessment .. or Phase 3 Trial of AzaSite Plusa" and DexaSitea"
[ Thu, Apr 14th 2011 ] - Market Wire
MedMira';s Multiplo Rapid Test to Be Used by Canadian Forces Health Services Group
[ Thu, Apr 14th 2011 ] - Market Wire
St. Jude Medical Announces Approval of ShockGuard .. onTxa" Programming for Unify and Fortify Implanta
[ Thu, Apr 14th 2011 ] - Market Wire
RXi Pharmaceuticals Completes Apthera Acquisition
[ Thu, Apr 14th 2011 ] - Market Wire
Human Genome Sciences Updates Investors on Progress of BENLYSTA® Launch and Future Priorities
[ Thu, Apr 14th 2011 ] - Market Wire
Medisafe 1 Technologies Closes $5 Million Equity Funding Agreement
Wed, April 13, 2011
[ Wed, Apr 13th 2011 ] - Market Wire
Gilead Sciences to Release First Quarter 2011 Financial Results on Wednesday, April 20, 2011
[ Wed, Apr 13th 2011 ] - Market Wire
Covidien Announces DuraSeala" Exact Spine Sealant Receives FDA Approval
[ Wed, Apr 13th 2011 ] - Market Wire
Tenet Healthcare Joins the Obama Administrationa?s Partnership for Patients
[ Wed, Apr 13th 2011 ] - Market Wire
Magellan Health Services Releases 2010 Annual Report
[ Wed, Apr 13th 2011 ] - Market Wire
Orthovita Launches the Aliquot Directional Bone Tamp
[ Wed, Apr 13th 2011 ] - Market Wire
Stellar Pharmaceuticals Inc. and Watson Pharmaceu .. minate Uracyst(R) Supply and Licensing Agreements
[ Wed, Apr 13th 2011 ] - Market Wire
New Corporate Strategy; Ball Named Interim Chairman; Revenue Projections
[ Wed, Apr 13th 2011 ] - Market Wire
Volatility Persists for Xoma and Aastrom Biosciences
[ Wed, Apr 13th 2011 ] - Market Wire
Unigene Increases Support for Tarsa in Preparation for Oral Calcitonin NDA Submission
[ Wed, Apr 13th 2011 ] - Market Wire
Amunix Signs Research Collaboration With Biogen I .. ext Generation Long-Lasting Blood Factor Products
[ Wed, Apr 13th 2011 ] - Market Wire
BioSante Pharmaceuticals Announces Teva New Drug Application for Bio-T-Gela"
[ Wed, Apr 13th 2011 ] - Market Wire
Implant Sciences Announces Explosives Trace Detection Pioneer Dr. William McGann as Advisor
Tue, April 12, 2011
[ Tue, Apr 12th 2011 ] - Market Wire
The Law Office of Abe Shainberg Launches an Inves .. es of Fiduciary Duty by the Board of American Med
[ Tue, Apr 12th 2011 ] - Market Wire
Forest Laboratories Announces Successful Completi .. ender Offer for Securities of Clinical Data, Inc.
[ Tue, Apr 12th 2011 ] - Market Wire
Fero Industries Appoints Lopez as Chief Operating Officer
[ Tue, Apr 12th 2011 ] - Market Wire
dermaPACE Pivotal Phase III Clinical Trial Result .. atment to Be Presented at the Symposium on Advanc
[ Tue, Apr 12th 2011 ] - Market Wire
Zynex Prepares for First Clinical Evaluation of Blood Volume Monitor Medical Device
[ Tue, Apr 12th 2011 ] - Market Wire
UnitedHealth Group anuncia la marca principal "Optum" para sus empresas de servicios sanitarios
[ Tue, Apr 12th 2011 ] - Market Wire
Teleflex Announces First Quarter 2011 Conference Call Information
[ Tue, Apr 12th 2011 ] - Market Wire
Skystar Bio-Pharmaceutical Reports Record Fourth Quarter and Fiscal Year 2010 Financial Results
[ Tue, Apr 12th 2011 ] - Market Wire
Das fortgesetzte Engagement von Biogen Idec fr Me .. uf der 63. Jahrestagung der amerikanischen Academ
[ Tue, Apr 12th 2011 ] - Market Wire
AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors
[ Tue, Apr 12th 2011 ] - Market Wire
Illumina to Announce First Quarter 2011 Financial Results on Tuesday, April 26, 2011
[ Tue, Apr 12th 2011 ] - Market Wire
Merck & Co., Inc., und Sun Pharma grnden Joint Ve .. marktung neuartiger Formulierungen und Kombinatio
Mon, April 11, 2011
[ Mon, Apr 11th 2011 ] - Market Wire
Nasce la joint venture tra Merck & Co., Inc., e S .. a commercializzazione di nuove formulazioni e com
[ Mon, Apr 11th 2011 ] - Market Wire
Prana Secures Key PBT2 Patent in Japan and Completes Core IP Suite
[ Mon, Apr 11th 2011 ] - Market Wire
Kendall Law Group Investigates American Medical Systems Holdings Inc. Acquisition for Shareholders
[ Mon, Apr 11th 2011 ] - Market Wire
Immunovaccine Reports Positive Interim Data from .. -0907 in Patients With Breast, Ovarian and Prosta
[ Mon, Apr 11th 2011 ] - Market Wire
VIVITROL® to be Featured in Data Presentations a .. American Society of Addiction Medicine Conference
[ Mon, Apr 11th 2011 ] - Market Wire
AVI BioPharma Receives Approval of Nonproprietary .. henne Muscular Dystrophy Therapeutic Candidate, A
[ Mon, Apr 11th 2011 ] - Market Wire
D. Medical Issued Drug Delivery Device and Method Patent in Japan
[ Mon, Apr 11th 2011 ] - Market Wire
(OTCBB: RGIN) Has PermaDerm Designated as a Combination Product by the FDA
[ Mon, Apr 11th 2011 ] - Market Wire
Cytokinetics Announces Data From Phase IIa "Evide .. of CK-2017357 in Patients With Amyotrophic Later
[ Mon, Apr 11th 2011 ] - Market Wire
Capital Senior Living Corporation Completes the Spring Meadows Transaction
[ Mon, Apr 11th 2011 ] - Market Wire
Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter
[ Mon, Apr 11th 2011 ] - Market Wire
TechniScan's Breast Imaging Science Featured at National Ultrasound Conference
Sun, April 10, 2011
[ Sun, Apr 10th 2011 ] - Market Wire
Pieris to Present at BioCentury Future Leaders in the Biotech Industry Conference
Sat, April 9, 2011
[ Sat, Apr 09th 2011 ] - Market Wire
Teva Announces Webcast on Results from Phase III .. RO Study of Oral Laquinimod in Multiple Sclerosis
[ Sat, Apr 09th 2011 ] - Market Wire
MannKind Provides Regulatory Update
Fri, April 8, 2011
[ Fri, Apr 08th 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Inves .. es of Fiduciary Duty by the Board of Inspire Phar
[ Fri, Apr 08th 2011 ] - Market Wire
30 a.m. Eastern Time Monday, April 11 to Discuss .. 3 Trial Results for Dimebon in Huntington Disease
[ Fri, Apr 08th 2011 ] - Market Wire
Curis to Present at the 18th Annual Future Leaders inthe Biotech Industry Conference
[ Fri, Apr 08th 2011 ] - Market Wire
Medwell Capital Announces that Mimetogen Pharmace .. Recruitment in Phase II Clinical Trial for Dry E
[ Fri, Apr 08th 2011 ] - Market Wire
AVI BioPharma to Present Company Overview at the .. Future Leaders in the Biotech Industry Conference
[ Fri, Apr 08th 2011 ] - Market Wire
BIOLASE Technology to Raise Approximately $1.80 M .. n From Institutional Investors at $5.60 per Share
[ Fri, Apr 08th 2011 ] - Market Wire
Medgenics Announces Pricing of U.S. Initial Public Offering
[ Fri, Apr 08th 2011 ] - Market Wire
ANAVEX APPOINTS DR. CHRISTOPHER SHACKLETON AS AN ADVISOR
[ Fri, Apr 08th 2011 ] - Market Wire
Renegade Petroleum Ltd. Announces Exercise of Over-Allotment Option
[ Fri, Apr 08th 2011 ] - Market Wire
Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 15, 2011
[ Fri, Apr 08th 2011 ] - Market Wire
Skystar to Release Fourth Quarter and Full Fiscal Year 2010 Results on Monday, April 11, 2011
[ Fri, Apr 08th 2011 ] - Market Wire
RXi Pharmaceuticals to Webcast Presentation at Bi .. Future Leaders in the Biotech Industry Conference
Thu, April 7, 2011
[ Thu, Apr 07th 2011 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES C .. ISCUSS RESULTS OF THE YEAR-END AND FOURTH QUARTER
[ Thu, Apr 07th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Shareholder Invest .. quisition of Inspire Pharmaceuticals, Inc. - ISPH
[ Thu, Apr 07th 2011 ] - Market Wire
Healthways Awarded Contract to Expand National Ch .. gram in France and Francea?s Overseas Territories
[ Thu, Apr 07th 2011 ] - Market Wire
Lakeland Industries, Inc. Reports Fiscal 2011 Fourth Quarter and Full Year Financial Results
[ Thu, Apr 07th 2011 ] - Market Wire
Sentinel Rock Oil Inc. and Sundance Energy Corpor .. tion Announce Filing of Filing Statement on Sedar
[ Thu, Apr 07th 2011 ] - Market Wire
Volunteering Does a Body Good
[ Thu, Apr 07th 2011 ] - Market Wire
BELLUS HEALTH ISSUES SHARES IN FINAL PAYMENT FOR THE EXERCISE OF ITS LEASE TERMINATION OPTION
[ Thu, Apr 07th 2011 ] - Market Wire
Apple Inc., Dell Inc., Google Inc., Microsoft Cor .. Pharmaceutical Company, Inc., N I S Holdings Corp
[ Thu, Apr 07th 2011 ] - Market Wire
Research on Eli Lilly & Co. and Abbott Laboratori .. s Look to Cancer, China and the Heart to Fill Pat
[ Thu, Apr 07th 2011 ] - Market Wire
BIOLASE to Adopt Direct and Multi-Distributor Sales Model in Germany
[ Thu, Apr 07th 2011 ] - Market Wire
Lpath Initiates Enrollment of iSONEP Phase 1b/2a Proof-of-Concept Trial
[ Thu, Apr 07th 2011 ] - Market Wire
Marina Biotech Initiates Dosing in the Phase 1b/2a START-FAP Clinical Trial of CEQ508
Wed, April 6, 2011
[ Wed, Apr 06th 2011 ] - Market Wire
Briscoe Law Firm and Powers Taylor LLP Investigat .. nc. for Shareholders Concerning Merck Acquisition
[ Wed, Apr 06th 2011 ] - Market Wire
Viking Systems Expects Record Quarterly Revenues for First Quarter 2011
[ Wed, Apr 06th 2011 ] - Market Wire
DERMAXAR Issues Clarification Statement
[ Wed, Apr 06th 2011 ] - Market Wire
AVI BioPharma Announces Exercise of Underwriters' .. on and Closing of Public Offering of Common Stock
[ Wed, Apr 06th 2011 ] - Market Wire
Eckert & Ziegler Withdraws Offer to Acquire Theragenics
[ Wed, Apr 06th 2011 ] - Market Wire
Assisted Living Concepts, Inc. Schedules First Quarter Financial Results Conference Call
[ Wed, Apr 06th 2011 ] - Market Wire
Citigroup Inc., National Semiconductor Corp., For .. ration, Intel Corporation, Dynatronics Corp., N I
[ Wed, Apr 06th 2011 ] - Market Wire
BIOLASE Announces That It Expects Revenues for First Quarter to Exceed Previous Guidance
[ Wed, Apr 06th 2011 ] - Market Wire
Four AACR Presentations Highlight Broad Therapeut .. f Peregrine's First-in-Class PS-Targeting Platfor
[ Wed, Apr 06th 2011 ] - Market Wire
Schizophrenia Reviewed by NeuroInvestment
[ Wed, Apr 06th 2011 ] - Market Wire
New Smartphone Application Helps Get People Walking
[ Wed, Apr 06th 2011 ] - Market Wire
Health Net Supports Tragedy Assistance Program for Survivorsa? Honor Guard Gala
Tue, April 5, 2011
[ Tue, Apr 05th 2011 ] - Market Wire
BioClinica, Inc. to Participate in Upcoming Indus .. onstrate Global Technologya"Enhanced Capabilities
[ Tue, Apr 05th 2011 ] - Market Wire
ZOLL Honored for Excellence in Customer Satisfaction for Tenth Consecutive Year
[ Tue, Apr 05th 2011 ] - Market Wire
Intellipharmaceutics International Inc. to Presen .. h Brothers 8th Annual Small Cap Equity Conference
[ Tue, Apr 05th 2011 ] - Market Wire
DARA Biosciences, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference
[ Tue, Apr 05th 2011 ] - Market Wire
Exelixis Announces April 7th Webcast of Presentat .. at the Leerink Swann Cancer Roundtable Conference
[ Tue, Apr 05th 2011 ] - Market Wire
American Medical Systems First Quarter 2011 Earnings Conference Call May 3, 2011
[ Tue, Apr 05th 2011 ] - Market Wire
CTD Holdings, Inc. Reports Record 2010 Sales
[ Tue, Apr 05th 2011 ] - Market Wire
Yellowhead Mining Announces Closing of Bought Dea .. te Placement for Gross Proceeds of CDN$20,488,000
[ Tue, Apr 05th 2011 ] - Market Wire
Export Agreement Signed for Causeway Oil
[ Tue, Apr 05th 2011 ] - Market Wire
Yellowhead Mining Inc. Appoints New Advisors to the Board
[ Tue, Apr 05th 2011 ] - Market Wire
Daxor Announces Publication of Research Article W .. olume Analyzer (BVA-100) Can Distinguish True Ane
[ Tue, Apr 05th 2011 ] - Market Wire
Peregrine's PS-Targeting Antibody Significantly I .. t of Sorafenib in Models of Advanced Liver Cancer
Mon, April 4, 2011
[ Mon, Apr 04th 2011 ] - Market Wire
Cambridge Heart Appoints New Vice President
[ Mon, Apr 04th 2011 ] - Market Wire
New International Surgical Products Business Prov .. cing Medline's Evidence-Based Solutions Worldwide
[ Mon, Apr 04th 2011 ] - Market Wire
Noted Oregon Cardiologists Conduct First Study on .. ts Using VentriPoint 3D Heart Analysis Technology
[ Mon, Apr 04th 2011 ] - Market Wire
Rosetta Genomics Reports 2010 Fourth Quarter and Full Year Financial Results
[ Mon, Apr 04th 2011 ] - Market Wire
Implant Sciences Announces Fiscal 2011 Q2 Revenue .. 3,147,000, Up 422% vs. Same Period in Fiscal 2010
[ Mon, Apr 04th 2011 ] - Market Wire
Medisafe 1 Technologies Garners Interest From Mul .. al Medical Supplier Becton, Dickinson and Company
[ Mon, Apr 04th 2011 ] - Market Wire
Salix Reviews the International Liver Congress 20 .. e European Association for the Study of the Liver
[ Mon, Apr 04th 2011 ] - Market Wire
Abiomed Announces Schedule of Events at American College of Cardiology 2011 Scientific Conference
[ Mon, Apr 04th 2011 ] - Market Wire
Abiomed Announces Final PROTECT II Study Results .. ulation at American College of Cardiology 2011 Sc
[ Mon, Apr 04th 2011 ] - Market Wire
ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkina?s Lymphoma
[ Mon, Apr 04th 2011 ] - Market Wire
AngioDynamics Launches the Next Generation DuraMax® Stepped-Tip Chronic Dialysis Catheter
[ Mon, Apr 04th 2011 ] - Market Wire
ImmunoGen, Inc. Announces First Data for its Nove .. erapeutic for Ovarian Cancer and Other Carcinomas
Sun, April 3, 2011
[ Sun, Apr 03rd 2011 ] - Market Wire
Antrim Energy and Partners to Drill East Fyne Well, UK North Sea
[ Sun, Apr 03rd 2011 ] - Market Wire
Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
[ Sun, Apr 03rd 2011 ] - Market Wire
Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC
[ Sun, Apr 03rd 2011 ] - Market Wire
Edwards Lifesciences Achieves Primary Endpoint in .. theter Valve Study of High-Risk Surgical Patients
Sat, April 2, 2011
[ Sat, Apr 02nd 2011 ] - Market Wire
Orthofix Appoints Vicente Trelles as Senior Vice .. sident, World Wide Operations and Shared Services
[ Sat, Apr 02nd 2011 ] - Market Wire
Investigational Compound PEG-Interferon Lambda Ac .. with Fewer Flu-Like and Musculoskeletal Symptoms
[ Sat, Apr 02nd 2011 ] - Market Wire
Medtronic Announces FDA Approval of InterStim® Therapy for Bowel Control
[ Sat, Apr 02nd 2011 ] - Market Wire
MEDNAX 2011 First Quarter Conference Call/Webcast Scheduled for Tuesday May 3, 2011
Fri, April 1, 2011
[ Fri, Apr 01st 2011 ] - Market Wire
Shoal Point Energy Ltd. Provides 3K39 Well Update
[ Fri, Apr 01st 2011 ] - Market Wire
AdCare Health Systems Closes $2.1 Million Convert .. nt and Secures $1.4 Million Bridge Loan Financing
[ Fri, Apr 01st 2011 ] - Market Wire
MedMira Announces Second Quarter Results
[ Fri, Apr 01st 2011 ] - Market Wire
LABOPHARM RECEIVES NOTICE FROM NASDAQ REGARDING MINIMUM MARKET VALUE OF LISTED SECURITIES
[ Fri, Apr 01st 2011 ] - Market Wire
PromiusTM Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
[ Fri, Apr 01st 2011 ] - Market Wire
Data on IPX066 APEX-PD Phase III Study for the Tr .. s Disease to be Presented at the American Academy
[ Fri, Apr 01st 2011 ] - Market Wire
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
[ Fri, Apr 01st 2011 ] - Market Wire
St Eugene Commences 2011 Exploration Program at Tartan Lake Mine Project
[ Fri, Apr 01st 2011 ] - Market Wire
Equity Research on Aetna Inc. and Unitedhealth Gr .. nc. - Health Care Providers Positioned for Growth
[ Fri, Apr 01st 2011 ] - Market Wire
Equity Research on Medtronic Inc. and St. Jude Me .. , Implantable Defibrillators Pumping Up Medical A
[ Fri, Apr 01st 2011 ] - Market Wire
AVI BioPharma Prices $30.0 Million Public Offering of Common Stock
[ Fri, Apr 01st 2011 ] - Market Wire
MEDNAX Announces the Acquisition of Practices in San Antonio, TX and Miami, FL
Thu, March 31, 2011
[ Thu, Mar 31st 2011 ] - Market Wire
AKELA PHARMA REPORTS RESULTS THE THREE MONTHS AND YEAR ENDED 2010
[ Thu, Mar 31st 2011 ] - Market Wire
Bio-Path Holdings Reports Fiscal Year 2010 Operational and Financial Results
[ Thu, Mar 31st 2011 ] - Market Wire
Allezoe (ALZM) Announces Organ Transport Systems Secures European Patent Rights
[ Thu, Mar 31st 2011 ] - Market Wire
Allezoe Medical Holdings Announces Initial Funding, Condemns Unauthorized Marketing Program
[ Thu, Mar 31st 2011 ] - Market Wire
SciClone Pharmaceuticals to Provide Financial Update on April 1
[ Thu, Mar 31st 2011 ] - Market Wire
SciClone Pharmaceuticals Provides Fourth Quarter and Year End 2010 Results and 2011 Guidance

Corporate Profile's CPReports.com Publishes RAY DIRKS Research's Update on Neostem, Inc.


//health-fitness.news-articles.net/content/2011/ .. -ray-dirks-research-s-update-on-neostem-inc.html
Published in Health and Fitness on Tuesday, April 12th 2011 at 9:35 GMT by Market Wire   Print publication without navigation


NEW YORK, NY--(Marketwire - April 12, 2011) - Corporate Profile's financial website [ www.CPreports.com ] announces report by Ray Dirks Research on Neostem, Inc. (NYSE Amex: [ NBS ]).

To view report go to: [ www.CPReports.com ] or [ http://www.cpreports.com/?p=989 ]

About CPreports.com
CPReports.com features Gene Marcial, Ray Dirks and Goldman Small Cap Research. The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary. Content is focused on what is going on in the stock market and on Wall Street.

About Corporate Profile.com
[ www.CorporateProfile.com ] is a broadcasting website where Fashion meets Finance, merging two mainstream industries results in a unique platform for today's hottest tips and market info.

About Ray Dirks Research
Ray Dirks came to Wall Street with Goldman, Sachs & Co. in 1963 where he was established as the leading insurance stock analyst dealing with institutional investors and high-net worth investors both in the U.S. and internationally. Ray's research includes Healthcare Stocks and Special Situations. Ray has written two books, "The Great Wall Street Scandal" and "Heads You Win, Tails You Win," published by McGraw-Hill and Bantam Books respectively. He continues to provide research to institutions and individuals. Ray can be reached at: [ rdirks@nyc.rr.com ]

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation.


Publication Contributing Sources